PubRank

R E O'Hehir

Author PubWeight™ 72.30‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008 12.35
2 Practical guide to skin prick tests in allergy to aeroallergens. Allergy 2011 2.51
3 Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol 2012 2.17
4 Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice. J Exp Med 1993 1.71
5 Major histocompatibility complex independent clonal T cell anergy by direct interaction of Staphylococcus aureus enterotoxin B with the T cell antigen receptor. J Exp Med 1992 1.37
6 Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper. Allergy 2010 1.24
7 The use of nitrocellulose immunoblots for the analysis of antigen recognition by T lymphocytes. J Immunol Methods 1988 1.17
8 Functional evidence for a monoclonal antibody that binds to the human IL-4 receptor. Immunology 1988 1.12
9 In vivo clonal dominance and limited T-cell receptor usage in human CD4+ T-cell recognition of house dust mite allergens. Proc Natl Acad Sci U S A 1993 1.02
10 CD28 mRNA rapidly decays when activated T cells are functionally anergized with specific peptide. Int Immunol 1993 1.02
11 Shellfish allergy. Clin Exp Allergy 2010 1.01
12 Localization of the immunologic activity in the superantigen Staphylococcal enterotoxin B using truncated recombinant fusion proteins. J Immunol 1992 0.97
13 Peptide-induced nonresponsiveness of HLA-DP restricted human T cells reactive with Dermatophagoides spp. (house dust mite). J Allergy Clin Immunol 1992 0.96
14 Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper. Int Arch Allergy Immunol 2012 0.96
15 IgE cross-reactivity between the major peanut allergen Ara h 2 and tree nut allergens. Mol Immunol 2006 0.93
16 Follistatin is a candidate endogenous negative regulator of activin A in experimental allergic asthma. Clin Exp Allergy 2006 0.93
17 Antigen-induced neutrophil chemotactic factor from cloned human T lymphocytes. Immunology 1988 0.93
18 Uncoupling of cytokine mRNA expression and protein secretion during the induction phase of T cell anergy. J Immunol 1992 0.93
19 Role of intravenous immunoglobulin in severe steroid-dependent asthma. Intern Med J 2003 0.92
20 Omalizumab is effective in treating systemic mastocytosis in a nonatopic patient. Allergy 2009 0.92
21 Immunological analysis of allergenic cross-reactivity between peanut and tree nuts. Clin Exp Allergy 2003 0.92
22 VH gene usage in immunoglobulin E responses of seasonal rhinitis patients allergic to grass pollen is oligoclonal and antigen driven. Clin Exp Allergy 2004 0.91
23 Clonal analysis of the atopic immune response to the group 2 allergen of Dermatophagoides spp.: identification of HLA-DR and -DQ restricted T cell epitopes. Int Immunol 1993 0.91
24 Overlapping T-cell epitopes in the group I allergen of Dermatophagoides species restricted by HLA-DP and HLA-DR class II molecules. J Allergy Clin Immunol 1994 0.91
25 Identification of two binding sites in staphylococcal enterotoxin B that confer specificity for TCR V beta gene products. Int Immunol 1994 0.89
26 Synergy between dexamethasone and interleukin-5 for the induction of major histocompatibility complex class II expression by human peripheral blood eosinophils. Blood 1994 0.88
27 Contribution of T-cell receptor-contacting and peptide-binding residues of the class II molecule HLA-DR4 Dw10 to serologic and antigen-specific T-cell recognition. Hum Immunol 1991 0.87
28 Oligoclonal V gene usage by T lymphocytes in bronchoalveolar lavage fluid from sarcoidosis patients. Am J Respir Cell Mol Biol 1996 0.86
29 Prevalence of severe ant-venom allergy in southeastern Australia. J Allergy Clin Immunol 1998 0.86
30 Polyclonal and clonal analysis of human CD4+ T-lymphocyte responses to nut extracts. Immunology 1995 0.86
31 An unfolded variant of the major peanut allergen Ara h 2 with decreased anaphylactic potential. Clin Exp Allergy 2012 0.86
32 Successful desensitization of two patients who previously developed Stevens-Johnson syndrome while receiving trimethoprim-sulfamethoxazole. Clin Infect Dis 1997 0.85
33 Differential induction of the NF-AT complex during restimulation and the induction of T-cell anergy. Hum Immunol 1995 0.84
34 The effects of changes at peptide residues contacting MHC class II T-cell receptor on antigen recognition and human Th0 cell effector function. Immunology 1995 0.84
35 Prevalence of IgE-mediated allergy to latex in hospital nursing staff. Aust N Z J Med 1997 0.84
36 Allergen immunotherapy: current and new therapeutic strategies. Expert Opin Investig Drugs 2000 0.84
37 Altered T cell ligands derived from a major house dust mite allergen enhance IFN-gamma but not IL-4 production by human CD4+ T cells. J Immunol 1996 0.84
38 Induction of T 'regulatory' cells by standardized house dust mite immunotherapy: an increase in CD4+ CD25+ interleukin-10+ T cells expressing peripheral tissue trafficking markers. Clin Exp Allergy 2004 0.83
39 Functional immunoglobulin E cross-reactivity between Pas n 1 of Bahia grass pollen and other group 1 grass pollen allergens. Clin Exp Allergy 2011 0.83
40 Ara h 1 CD4+ T cell epitope-based peptides: candidates for a peanut allergy therapeutic. Clin Exp Allergy 2013 0.82
41 Analysis of the basis of resistance and susceptibility of CD4+ T cells to human immunodeficiency virus (HIV)-gp120 induced anergy. Immunology 1992 0.81
42 Reversal of the inhibitory effects of HIV-gp120 on CD4+ T cells by stimulation through the CD28 pathway. Clin Exp Immunol 1996 0.81
43 Characterization of the T-cell epitopes of a major peanut allergen, Ara h 2. Allergy 2005 0.81
44 HLA-DR4Dw4-restricted T cell recognition of self antigen(s) in the rheumatoid synovial compartment. Int Immunol 1991 0.81
45 Acute myopathy in severe acute asthma treated with intravenously administered corticosteroids. Am Rev Respir Dis 1988 0.81
46 Latex allergy: a model for therapy. Clin Exp Allergy 2008 0.81
47 What can we learn from studies of lymphocytes present in allergic-reaction sites? J Allergy Clin Immunol 1992 0.81
48 Leukotriene release enhancing factor. Purification, specific allergen induction, and further biologic properties. J Immunol 1989 0.81
49 Macadamia nut anaphylaxis: demonstration of specific IgE reactivity and partial cross-reactivity with hazelnut. J Allergy Clin Immunol 1999 0.80
50 HLA class II restriction specificity of Dermatophagoides spp. reactive T lymphocyte clones that support IgE synthesis. Clin Exp Allergy 1989 0.80
51 Adverse events associated with rush hymenoptera venom immunotherapy. Med J Aust 2001 0.79
52 A novel grass pollen allergen mimotope identified by phage display peptide library inhibits allergen-human IgE antibody interaction. FEBS Lett 2001 0.79
53 The evolution of oral immunotherapy for the treatment of peanut allergy. Clin Exp Allergy 2011 0.79
54 The domain structure and functional relationships in the bacterial superantigen, SEB. Biol Chem Hoppe Seyler 1995 0.78
55 Increased allergen concentration enhances IFN-gamma production by allergic donor T cells expressing a peripheral tissue trafficking phenotype. Allergy 2004 0.78
56 The hevein domain of the major latex-glove allergen Hev b 6.01 contains dominant T cell reactive sites. Clin Exp Allergy 2004 0.78
57 Molecular cloning, expression and immunological characterisation of Lol p 5C, a novel allergen isoform of rye grass pollen demonstrating high IgE reactivity. FEBS Lett 1999 0.78
58 Experience with a new commercial skin testing kit to identify IgE-mediated penicillin allergy. Intern Med J 2008 0.78
59 Particulate masks and non-powdered gloves reduce latex allergen inhaled by healthcare workers. Clin Exp Allergy 2002 0.77
60 T-cell receptor peptides that inhibit the T-cell response to allergen induce transforming growth factor-beta 1 production. J Allergy Clin Immunol 1996 0.77
61 Immunogenetic characteristics of immunoglobulin E in allergic disease. Clin Exp Allergy 2008 0.77
62 Specific monoclonal antibodies and human immunoglobulin E show that Hev b 5 is an abundant allergen in high protein powdered latex gloves. Clin Exp Allergy 2002 0.76
63 T-cell receptor contact and MHC binding residues of a major rye grass pollen allergen T-cell epitope. J Allergy Clin Immunol 1999 0.76
64 Chlorhexidine anaphylaxis: a case report and review of the literature. Intern Med J 2001 0.75
65 Immunotherapy in asthma. Thorax 1997 0.75
66 Characterization of the human T cell response to rye grass pollen allergens Lol p 1 and Lol p 5. Allergy 2002 0.75
67 Functional analysis of cross-reactive immunoglobulin E antibodies: peanut-specific immunoglobulin E sensitizes basophils to tree nut allergens. Clin Exp Allergy 2005 0.75
68 Emergency treatment of asthma: how are we doing? Intern Med J 2003 0.75
69 Blocking antibodies in allergen immunotherapy: the Yin and Yang. Clin Exp Allergy 2004 0.75
70 Inhibition of human T-cell responses to house dust mite allergens by a T-cell receptor peptide. J Allergy Clin Immunol 1994 0.75
71 Treating allergy: where to from here? Intern Med J 2009 0.75
72 Latex allergy: towards immunotherapy for health care workers. Clin Exp Allergy 2002 0.75
73 Differential dependence of TH-0, TH-1 and TH-2 CD4+ T cells on co-stimulatory activity provided by the accessory molecule LFA-1. Clin Exp Allergy 1995 0.75
74 Clonal analysis of CD4 mediated accessory function on the effector activity of human CD4+ T cell subsets. Clin Exp Allergy 1995 0.75
75 What determines asthma phenotype? Respiratory infections and asthma. Am J Respir Crit Care Med 2000 0.75
76 T lymphocytes in allergen-induced late-phase reactions and asthma. Int Arch Allergy Appl Immunol 1989 0.75
77 Peanut allergy. Med J Aust 1997 0.75
78 Murine B-cell and T-cell epitopes of the allergen Hev b 5 from natural rubber latex. Mol Immunol 1999 0.75
79 Peptide mediated regulation of allergen specific immune responses. Adv Exp Med Biol 1996 0.75